Overzicht van nieuwe geneesmiddelen (ATC-codes) in 2013 met de vergoeding per jaar
- Raming voor de totale Zvw-populatie
| Introductiejaar | ATC-code | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | A07AA12 Fidaxomicine | 49.204 | 66.820 | 99.737 | 136.258 | 101.763 | 123.452 | 120.621 | 183.962 | 232.853 | 403.420 | 585.917 | 968.403 |
| A10BK01 Dapagliflozine | 44.478 | 474.580 | 922.236 | 1.590.133 | 2.279.801 | 2.952.407 | 2.900.440 | 3.346.217 | 5.403.624 | 21.125.130 | 39.787.656 | 58.320.351 | |
| D06BB12 Sinecatechins | 131.917 | 529.807 | 266.461 | 207.569 | 176.407 | 164.023 | 139.650 | 134.218 | 107.590 | 90.189 | 117.763 | 141.222 | |
| D06BX02 Ingenolmebutaat | 454.455 | 1.329.103 | 905.859 | 803.305 | 622.923 | 445.311 | 355.621 | 13.633 | . | . | . | . | |
| D07XC02 Desoximetason met overige middelen | 10.241 | 657.010 | 789.382 | 792.704 | 798.714 | 778.318 | 787.027 | 734.142 | 738.674 | 860.279 | 1.039.687 | 1.068.084 | |
| D11AH04 Alitretinoine | 281.425 | 3.698.769 | 5.024.340 | 5.689.445 | 5.831.430 | 6.738.346 | 7.917.633 | 6.801.945 | 4.879.965 | 4.970.875 | 5.167.987 | 5.160.761 | |
| G03XB02 Ulipristal | 128.346 | 393.715 | 796.300 | 1.454.185 | 1.931.758 | 602.504 | 448.369 | 100.459 | 14.044 | 42.857 | 56.887 | 61.426 | |
| G04CA53 Tamsulosine met solifenacine | 133.634 | 1.118.313 | 1.626.758 | 2.142.822 | 2.649.121 | 2.961.610 | 3.333.459 | 3.545.265 | 3.862.794 | 4.347.027 | 4.654.993 | 4.696.802 | |
| H01CB05 Pasireotide | 229.243 | 256.675 | 424.118 | 2.317.993 | 2.114.892 | 2.270.972 | 2.429.631 | 2.433.836 | 2.262.265 | 2.366.287 | 2.388.674 | 2.394.709 | |
| J05AR09 Emtricitabine met tenofovir elvitegravir en cobicistat | 114.670 | 6.489.112 | 13.214.024 | 13.914.268 | 9.642.229 | 8.883.960 | 7.688.716 | 6.829.204 | 5.405.025 | 4.862.461 | 4.129.047 | 3.593.164 | |
| N06DA02 Donepezil | 19.472 | 94.493 | 95.905 | 56.760 | 35.116 | 35.632 | 40.035 | 60.163 | 38.917 | 17.434 | 41.770 | 55.287 | |
| N07BB05 Nalmefeen | 18.791 | 242.102 | 229.273 | 239.455 | 194.895 | 190.582 | 217.109 | 208.499 | 171.278 | 147.260 | 146.186 | 129.530 | |
| R03AL04 Indacaterol met glycopyrroniumbromide | 118.821 | 2.768.311 | 4.579.467 | 4.926.399 | 5.121.651 | 5.052.269 | 4.706.555 | 4.185.312 | 3.251.627 | 2.880.661 | 2.543.091 | 2.200.244 | |
| R03BB05 Aclidiniumbromide | 337.462 | 1.100.933 | 1.496.974 | 1.551.113 | 1.437.142 | 1.375.128 | 1.253.494 | 1.191.497 | 1.099.634 | 1.058.683 | 1.039.714 | 992.327 | |
| R03BB06 Glycopyrroniumbromide | 2.121.180 | 2.939.864 | 2.896.120 | 2.673.016 | 2.379.450 | 2.101.782 | 1.821.777 | 1.574.073 | 1.219.667 | 1.125.196 | 960.268 | 815.925 | |
| Totaal | 4.193.337 | 22.159.609 | 33.366.955 | 38.495.426 | 35.317.292 | 34.676.296 | 34.160.137 | 31.342.426 | 28.687.956 | 44.297.758 | 62.659.639 | 80.598.235 |